257 related articles for article (PubMed ID: 10654935)
1. FHL2, a novel tissue-specific coactivator of the androgen receptor.
Müller JM; Isele U; Metzger E; Rempel A; Moser M; Pscherer A; Breyer T; Holubarsch C; Buettner R; Schüle R
EMBO J; 2000 Feb; 19(3):359-69. PubMed ID: 10654935
[TBL] [Abstract][Full Text] [Related]
2. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
[TBL] [Abstract][Full Text] [Related]
5. Four and a half LIM domain 2 alters the impact of aryl hydrocarbon receptor on androgen receptor transcriptional activity.
Kollara A; Brown TJ
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):51-8. PubMed ID: 19815066
[TBL] [Abstract][Full Text] [Related]
6. The LIM-only coactivator FHL2 modulates WT1 transcriptional activity during gonadal differentiation.
Du X; Hublitz P; Günther T; Wilhelm D; Englert C; Schüle R
Biochim Biophys Acta; 2002 Aug; 1577(1):93-101. PubMed ID: 12151099
[TBL] [Abstract][Full Text] [Related]
7. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.
Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y
Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728
[TBL] [Abstract][Full Text] [Related]
8. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
[TBL] [Abstract][Full Text] [Related]
9. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
Heemers HV; Regan KM; Dehm SM; Tindall DJ
Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2.
Hill AA; Riley PR
Mol Cell Biol; 2004 Nov; 24(22):9835-47. PubMed ID: 15509787
[TBL] [Abstract][Full Text] [Related]
11. Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.
Kollara A; Brown TJ
Int J Biochem Cell Biol; 2009 May; 41(5):1182-8. PubMed ID: 19015043
[TBL] [Abstract][Full Text] [Related]
12. Identification of the LIM protein FHL2 as a coactivator of beta-catenin.
Wei Y; Renard CA; Labalette C; Wu Y; Lévy L; Neuveut C; Prieur X; Flajolet M; Prigent S; Buendia MA
J Biol Chem; 2003 Feb; 278(7):5188-94. PubMed ID: 12466281
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the heart-specific LIM domain protein, FHL2, with DNA-binding nuclear protein, hNP220.
Ng EK; Chan KK; Wong CH; Tsui SK; Ngai SM; Lee SM; Kotaka M; Lee CY; Waye MM; Fung KP
J Cell Biochem; 2002; 84(3):556-66. PubMed ID: 11813260
[TBL] [Abstract][Full Text] [Related]
14. FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins.
Kobayashi S; Shibata H; Yokota K; Suda N; Murai A; Kurihara I; Saito I; Saruta T
Endocr Res; 2004 Nov; 30(4):617-21. PubMed ID: 15666801
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus.
Müller JM; Metzger E; Greschik H; Bosserhoff AK; Mercep L; Buettner R; Schüle R
EMBO J; 2002 Feb; 21(4):736-48. PubMed ID: 11847121
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 interacts with FHL2 and enhances FHL2 transactivation function.
Yan J; Zhu J; Zhong H; Lu Q; Huang C; Ye Q
FEBS Lett; 2003 Oct; 553(1-2):183-9. PubMed ID: 14550570
[TBL] [Abstract][Full Text] [Related]
17. The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein.
McLoughlin P; Ehler E; Carlile G; Licht JD; Schäfer BW
J Biol Chem; 2002 Oct; 277(40):37045-53. PubMed ID: 12145280
[TBL] [Abstract][Full Text] [Related]
18. The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1.
Morlon A; Sassone-Corsi P
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):3977-82. PubMed ID: 12644711
[TBL] [Abstract][Full Text] [Related]
19. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
Heitzer MD; DeFranco DB
Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
[TBL] [Abstract][Full Text] [Related]
20. Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
Govoni KE; Baylink DJ; Chen J; Mohan S
Calcif Tissue Int; 2006 Aug; 79(2):112-7. PubMed ID: 16927043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
